MENLO THERAPEUTICS INC's ticker is MNLO and the CUSIP is 586858102. A total of 56 filers reported holding MENLO THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $250,000 | +35.1% | 53,851 | +30.7% | 0.21% | +50.4% |
| Q3 2019 | $185,000 | +96.8% | 41,188 | +161.1% | 0.14% | +139.7% |
| Q2 2019 | $94,000 | -82.1% | 15,775 | -76.5% | 0.06% | -73.1% |
| Q1 2019 | $526,000 | -25.9% | 66,996 | -61.1% | 0.22% | -27.5% |
| Q4 2018 | $710,000 | – | 172,433 | – | 0.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DSC Advisors, L.P. | 4,359,030 | $7,541,000 | 8.27% |
| Healthcare Value Capital, LLC | 1,700,000 | $2,941,000 | 7.51% |
| 683 Capital Management, LLC | 5,550,208 | $9,602,000 | 0.77% |
| Perceptive Advisors | 22,876,410 | $39,576,000 | 0.64% |
| Vivo Capital, LLC | 3,643,824 | $6,304,000 | 0.45% |
| Monashee Investment Management LLC | 1,005,000 | $1,739,000 | 0.26% |
| MYDA Advisors LLC | 93,300 | $161,000 | 0.10% |
| Sofinnova Investments, Inc. | 725,571 | $1,256,000 | 0.08% |
| CAAS CAPITAL MANAGEMENT LP | 1,185,501 | $2,051,000 | 0.07% |
| Grace Capital | 36,012 | $62,000 | 0.05% |